ResearcherCentre Hospitalier Universitaire de BordeauxNo recent work listed
Claudia Pouypoudat
Matched on OpenAlex author ID A5109435849. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: none · 2021: 1 paper
Papers 2
- Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery. Co-author DOI 10.1080/0284186x.2021.1944662↗
- FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre. Co-author DOI 10.1016/j.dld.2019.03.004↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jean‐Frédéric Blanc · 2 shared papers, 2019–2021 · strength 0.19
- Paper Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to… DOI 10.1080/0284186x.2021.1944662↗
- Paper FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study fro… DOI 10.1016/j.dld.2019.03.004↗
- V. Vendrely · 2 shared papers, 2019–2021 · strength 0.19
- Paper Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to… DOI 10.1080/0284186x.2021.1944662↗
- Paper FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study fro… DOI 10.1016/j.dld.2019.03.004↗
- Étienne Buscail · 2 shared papers, 2019–2021 · strength 0.19
- Paper Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to… DOI 10.1080/0284186x.2021.1944662↗
- Paper FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study fro… DOI 10.1016/j.dld.2019.03.004↗
- Christophe Laurent · 2 shared papers, 2019–2021 · strength 0.19
- Paper Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to… DOI 10.1080/0284186x.2021.1944662↗
- Paper FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study fro… DOI 10.1016/j.dld.2019.03.004↗
- L. Chiche · 2 shared papers, 2019–2021 · strength 0.19
- Paper Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to… DOI 10.1080/0284186x.2021.1944662↗
- Paper FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study fro… DOI 10.1016/j.dld.2019.03.004↗
- Mario Terlizzi · 1 shared paper, 2021 · strength 0.11
- Christophe Cassinotto · 1 shared paper, 2019 · strength 0.08
- Sandrine Dabernat · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.